Lyn shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2Molecular therapy. Nucleic acidsSeptember 3, 2021Seok HJ, Choi YE, Choi JY, Yi JM, Kim EJ, Choi MY, Lee SJ, Bae IH.

(2) DC-SIGN-LEF1/TCF1-miR-185 feedback loop promotes colorectal cancer invasion and metastasisCell death and differentiationJanuary 1, 2020Yuan M, Zhang X, Zhang J, Wang K, Zhang Y, Shang W, Zhang Y, Cui J, Shi X, Na H, et al.

(3) Lyn regulates epithelial-mesenchymal transition in CS-exposed model through Smad2/3 signalingRespiratory researchSeptember 2, 2019Liang X, He X, Li Y, Wang J, Wu D, Yuan X, Wang X, Li G.

(6) Lyn kinase represses mucus hypersecretion by regulating IL-13-induced endoplasmic reticulum stress in asthmaEBioMedicineFebruary 1, 2017Wang X, Yang X, Li Y, Wang X, Zhang Y, Dai X, Niu B, Wu J, Yuan X, Xiong A, et al.

(7) Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancerOncogenesisAugust 18, 2014Zardan A, Nip KM, Thaper D, Toren P, Vahid S, Beraldi E, Fazli L, Lamoureux F, Gust KM, Cox ME, et al.

(8) Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite modelsJournal of immunology (Baltimore, Md. : 1950)December 1, 2013Li G, Fox J 3rd, Liu Z, Liu J, Gao GF, Jin Y, Gao H, Wu M.

(9) Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancerMolecular cancerJune 26, 2012Su N, Peng L, Xia B, Zhao Y, Xu A, Wang J, Wang X, Jiang B.

Lyn shRNA Plasmid (h)